Castrate-resistant prostate cancer (CRPC) is the lethal form of prostate cancer. Epithelial mesenchymal plasticity (EMP) has been associated with disease progression to CRPC. and prostate cancer therapies targeting the androgen signalling axis. including androgen deprivation therapy (ADT). https://www.marcelovicente.com/product-category/oxydant-creme-3-75-12-5-volume/